Myeloid-derived suppressor cell infiltration is associated with a poor prognosis in patients with hepatocellular carcinoma.
CD8+ T cell
T cell exhaustion
immune checkpoint inhibitor
tumor infiltrating lymphocyte
tumor microenvironment
Journal
Oncology letters
ISSN: 1792-1082
Titre abrégé: Oncol Lett
Pays: Greece
ID NLM: 101531236
Informations de publication
Date de publication:
Mar 2022
Mar 2022
Historique:
received:
09
10
2021
accepted:
10
12
2021
entrez:
14
2
2022
pubmed:
15
2
2022
medline:
15
2
2022
Statut:
ppublish
Résumé
The clinicopathological features of myeloid-derived suppressor cell (MDSC) and CD8
Identifiants
pubmed: 35154424
doi: 10.3892/ol.2022.13213
pii: OL-23-03-13213
pmc: PMC8822414
doi:
Types de publication
Journal Article
Langues
eng
Pagination
93Informations de copyright
Copyright: © Tomiyama et al.
Déclaration de conflit d'intérêts
The authors declare that they have no competing interests.
Références
Nat Rev Gastroenterol Hepatol. 2015 Dec;12(12):681-700
pubmed: 26484443
N Engl J Med. 2012 Jun 28;366(26):2455-65
pubmed: 22658128
Nat Rev Immunol. 2005 Aug;5(8):641-54
pubmed: 16056256
Cancer Res. 2017 May 15;77(10):2607-2619
pubmed: 28364000
Cancer Immunol Immunother. 2004 May;53(5):422-30
pubmed: 14648070
N Engl J Med. 2015 Oct 22;373(17):1627-39
pubmed: 26412456
Surg Today. 2012 May;42(5):435-40
pubmed: 22200757
Hepatol Commun. 2020 Dec 30;5(4):675-688
pubmed: 33860125
Nature. 2019 Jul;571(7764):211-218
pubmed: 31207603
Gut. 2018 May;67(5):931-944
pubmed: 28939663
Hepatol Res. 2017 Sep;47(10):1061-1071
pubmed: 27764536
Sci Transl Med. 2016 Mar 2;8(328):328rv4
pubmed: 26936508
J Hepatol. 2006 Aug;45(2):246-53
pubmed: 16580084
J Immunother Cancer. 2019 Nov 29;7(1):331
pubmed: 31783783
Cancer Metastasis Rev. 2011 Mar;30(1):83-95
pubmed: 21249423
J Transl Med. 2020 Oct 15;18(1):393
pubmed: 33059689
J Clin Invest. 2015 Sep;125(9):3356-64
pubmed: 26168215
Oncotarget. 2016 Apr 5;7(14):17565-78
pubmed: 27007050
Hepatology. 2016 Dec;64(6):2038-2046
pubmed: 27359084
Clin Cancer Res. 2010 Sep 15;16(18):4583-94
pubmed: 20702612
Oncology. 2017;92 Suppl 1:50-62
pubmed: 28147363
Hepatology. 2020 Dec;72(6):1987-1999
pubmed: 32112577
Cancers (Basel). 2021 Jul 21;13(15):
pubmed: 34359568
Ann Surg Oncol. 2014 Sep;21(9):3063-8
pubmed: 24719020
Hepatol Commun. 2020 Nov 24;5(2):334-348
pubmed: 33553979
Br J Cancer. 2018 Jul;119(1):80-88
pubmed: 29921949
Ann Surg. 2019 Mar;269(3):471-478
pubmed: 29206673
Trends Mol Med. 2019 Mar;25(3):198-214
pubmed: 30795972
Immunol Rev. 2008 Apr;222:180-91
pubmed: 18364002
Nat Rev Immunol. 2009 Mar;9(3):162-74
pubmed: 19197294
Cell Immunol. 2021 Apr;362:104302
pubmed: 33592540
Curr Cancer Drug Targets. 2020;20(1):3-18
pubmed: 31729943
Cancer Res. 2010 Apr 15;70(8):3052-61
pubmed: 20388795
Cancer Res. 2007 Nov 15;67(22):11021-8
pubmed: 18006848
Nat Commun. 2016 Jul 06;7:12150
pubmed: 27381735
J Immunol. 2001 Jan 1;166(1):678-89
pubmed: 11123353
Ann Surg Oncol. 2009 Dec;16(12):3299-307
pubmed: 19826875
Science. 2015 Apr 3;348(6230):56-61
pubmed: 25838373
Nat Rev Immunol. 2012 Mar 22;12(4):253-68
pubmed: 22437938